ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SEVEN EIGHT CAPITAL, LP | 19,075 | $680,024 | 0.08% |
| PINNACLE ASSOCIATES LTD | 119,355 | $4,255,006 | 0.08% |
| XTX Topco Ltd | 13,019 | $464,127 | 0.08% |
| ClearBridge Investments | 2,293,570 | $81,765,784 | 0.08% |
| Point72 Asset Management, L.P. | 716,462 | $25,541,870 | 0.08% |
| UBS OCONNOR LLC | 76,915 | $2,742,020 | 0.07% |
| MARSHALL WACE, LLP | 940,763 | $33,538,201 | 0.07% |
| Headlands Technologies LLC | 3,351 | $119,463 | 0.06% |
| PROFUND ADVISORS LLC | 30,061 | $1,071,675 | 0.06% |
| Y-Intercept (Hong Kong) Ltd | 15,442 | $550,507 | 0.05% |
| FIRST TRUST ADVISORS LP | 1,201,688 | $42,840,207 | 0.05% |
| WS MANAGEMENT LLLP | 15,885 | $566,300 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 19,751 | $704,123 | 0.04% |
| AIGEN INVESTMENT MANAGEMENT, LP | 6,732 | $239,996 | 0.04% |
| AXA S.A. | 344,499 | $12,281,389 | 0.04% |
| Pictet Asset Management Holding SA | 869,388 | $30,993,682 | 0.04% |
| Rafferty Asset Management, LLC | 183,051 | $6,525,768 | 0.04% |
| ALGERT GLOBAL LLC | 22,140 | $789 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 5,195,880 | $185,233,121 | 0.04% |
| Quarry LP | 4,200 | $149,730 | 0.04% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q3 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.